SCHEMBL23516096

SCHEMBL23516096

CN1C(=O)c2cccc(-n3c4ccccc4c4c(-c5ccncc5)cccc43)c2C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 3/20 0.40
▸ MEN1 O00255 5/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ USP2 O75604 3/20 0.37
▸ CASP1 P29466 3/20 0.37
▸ KEAP1 Q14145 2/20 0.37
▸ NFE2L2 Q16236 2/20 0.37
▸ BRCA1 P38398 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ BRD4 O60885 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ ATM Q13315 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CASP3 P42574 1/20 0.35
▸ POLB P06746 3/20 0.35
▸ HTR6 P50406 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23516354 0.92 MEN1 (0.38) MAPK14MEN1KMT2AUSP2CASP1
SCHEMBL23516170 0.90 MEN1 (0.38) MEN1KMT2AUSP2CASP1KEAP1
SCHEMBL23515969 0.89 MAPK14 (0.43) MAPK14BRD4HPGD
SCHEMBL23515907 0.88 DUSP3 (0.42) MAPK14MEN1KMT2AUSP2CASP1
SCHEMBL23516006 0.84 HSPA1A (0.43) MAPK14MEN1KMT2AUSP2KEAP1
SCHEMBL23516097 0.84 MAPK14 (0.41) MAPK14BRD4ROCK2CASP3
SCHEMBL23516356 0.84 MAPK14 (0.41) MAPK14ROCK2
SCHEMBL23516372 0.84 ALDH1A1 (0.44) MAPK14MEN1KMT2AHTTPDE10A
SCHEMBL23516316 0.84 BRD4 (0.39) MEN1KMT2AUSP2CASP1KEAP1
SCHEMBL23516357 0.83 MEN1 (0.40) MAPK14MEN1KMT2AUSP2CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276825-B2 Organic molecules for use in organic devices CYNORA GMBH (DE) 2022-03-15 — — US disclosed
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES CHRM1, C1S, DNMT3L MAPK14 2770/4885MEN1 887/4885KMT2A 1260/4885
US-11276825-B2 Organic molecules for use in organic devices AOX1, OR10J3, L1CAM MAPK14 3910/4885MEN1 2728/4885KMT2A 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback